tiprankstipranks
Trending News
More News >

Unicycive announces puvlication of OLC positive bioequivalence data

Unicycive Therapeutics (UNCY) announced that data from the Company’s oxylanthanum carbonate, OLC, bioequivalence study in healthy volunteers was published in the peer-reviewed journal, Clinical Therapeutics. The publication, entitled, “Two-Way Randomized Crossover Study to Establish Pharmacodynamic Bioequivalence Between Oxylanthanum Carbonate and Lanthanum Carbonate” described the study that established pharmacodynamic bioequivalence of OLC to Fosrenol. In the study, OLC was well tolerated and demonstrated bioequivalence to lanthanum carbonate.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue